{"items": "50", "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish", "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.", "feed": [{"title": "Johnson & Johnson Is a King of Dividend Safety", "url": "https://www.fool.com/investing/2024/04/29/johnson-johnson-is-a-king-of-dividend-safety/", "time_published": "20240429T142300", "authors": ["Matt DiLallo"], "summary": "The healthcare behemoth has fortified its dividend.", "banner_image": "https://media.ycharts.com/charts/5c2ee15090c73ff598de146acb419ed6.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.977154"}, {"topic": "Earnings", "relevance_score": "0.682689"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.380671, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.062926", "ticker_sentiment_score": "0.184192", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SWAV", "relevance_score": "0.062926", "ticker_sentiment_score": "0.173164", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.614836", "ticker_sentiment_score": "0.495553", "ticker_sentiment_label": "Bullish"}]}, {"title": "ENA Respiratory Announces FDA IND Clearance for its Prophylactic Intranasal INNA-051 - a First-in-Class Antiviral Innate Immunomodulator", "url": "https://www.benzinga.com/pressreleases/24/04/g38482503/ena-respiratory-announces-fda-ind-clearance-for-its-prophylactic-intranasal-inna-051-a-first-in-cl", "time_published": "20240429T080000", "authors": ["Globe Newswire"], "summary": "MELBOURNE, Australia, April 29, 2024 ( GLOBE NEWSWIRE ) -- ENA Respiratory, a clinical-stage pharmaceutical company developing innate immune modulators for the prevention of complications associated with respiratory viral infections in at-risk populations, announces today that the U.S.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.215658, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "JNJ", "relevance_score": "0.056674", "ticker_sentiment_score": "0.133947", "ticker_sentiment_label": "Neutral"}]}, {"title": "3 Unusual Income ETFs That May Be Just What You're Looking For", "url": "https://www.fool.com/investing/2024/04/28/3-unusual-income-etfs-that-may-be-just-what-youre/", "time_published": "20240428T131500", "authors": ["James Brumley"], "summary": "They may be off the beaten path, but these exchange-traded funds just might meet your unique income need.", "banner_image": "https://g.foolcdn.com/editorial/images/774402/one-thousand-dollars-1000-fanned-out.jpg", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.218539, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BLK", "relevance_score": "0.034039", "ticker_sentiment_score": "0.133002", "ticker_sentiment_label": "Neutral"}, {"ticker": "VZ", "relevance_score": "0.034039", "ticker_sentiment_score": "0.154281", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.034039", "ticker_sentiment_score": "0.154281", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "XOM", "relevance_score": "0.034039", "ticker_sentiment_score": "0.154281", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "2 Top Growth Stocks to Buy Right Now and Hold Forever", "url": "https://www.fool.com/investing/2024/04/28/2-top-growth-stocks-to-buy-now-and-hold-forever/", "time_published": "20240428T124500", "authors": ["Rachel Warren"], "summary": "These healthcare stocks can provide enviable long-term portfolio growth.", "banner_image": "https://g.foolcdn.com/editorial/images/773907/getty-couple-happy-in-kitchen.jpg", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.989041"}, {"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.318166, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "KVUE", "relevance_score": "0.043738", "ticker_sentiment_score": "0.142649", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRTX", "relevance_score": "0.087344", "ticker_sentiment_score": "0.23405", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MRNA", "relevance_score": "0.043738", "ticker_sentiment_score": "0.195492", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SWAV", "relevance_score": "0.043738", "ticker_sentiment_score": "0.184503", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ALPN", "relevance_score": "0.043738", "ticker_sentiment_score": "0.077297", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.216087", "ticker_sentiment_score": "0.249471", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Better Dividend Stock: AbbVie or Johnson & Johnson?", "url": "https://www.fool.com/investing/2024/04/28/better-dividend-stock-abbvie-or-johnson-johnson/", "time_published": "20240428T082000", "authors": ["Prosper Junior Bakiny"], "summary": "One thing is for sure: Dividend seekers can't go wrong with either.", "banner_image": "https://media.ycharts.com/charts/606ca6d7bad2ded63e4e23f32d1c43b2.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Earnings", "relevance_score": "0.918141"}], "overall_sentiment_score": 0.215112, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.596349", "ticker_sentiment_score": "0.286691", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABT", "relevance_score": "0.051221", "ticker_sentiment_score": "0.025897", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.479385", "ticker_sentiment_score": "0.29997", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "NAMIWalks Greater LA County Mental Health Festival Taking Place at LA State Historic Park", "url": "https://www.benzinga.com/pressreleases/24/04/n38476927/namiwalks-greater-la-county-mental-health-festival-taking-place-at-la-state-historic-park", "time_published": "20240427T153000", "authors": ["PRNewswire"], "summary": "LOS ANGELES, April 27, 2024 /PRNewswire/ -- The National Alliance on Mental Illness Greater L.A. County ( NAMI GLAC ) will celebrate its 20th annual NAMIWalks Greater LA County Mental Health Festival during Mental Health Awareness Month on Saturday, May 4, 2024.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.300726, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "JNJ", "relevance_score": "0.064973", "ticker_sentiment_score": "0.198444", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Johnson & Johnson Stock: Buy, Sell, or Hold?", "url": "https://www.fool.com/investing/2024/04/27/johnson-johnson-stock-buy-sell-or-hold/", "time_published": "20240427T114500", "authors": ["David Jagielski"], "summary": "Is this top healthcare stock worth adding to your portfolio today?", "banner_image": "https://g.foolcdn.com/editorial/images/773651/a-doctor-using-a-stethoscope.jpg", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.5855"}, {"topic": "Earnings", "relevance_score": "0.714479"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.210394, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "JNJ", "relevance_score": "0.330876", "ticker_sentiment_score": "0.124083", "ticker_sentiment_label": "Neutral"}]}, {"title": "AbbVie  ( ABBV )  Beats on Q1 Earnings & Sales, Ups '24 EPS View", "url": "https://www.zacks.com/stock/news/2263588/abbvie-abbv-beats-on-q1-earnings-sales-ups-24-eps-view", "time_published": "20240426T161000", "authors": ["Zacks Equity Research"], "summary": "AbbVie's (ABBV) first-quarter earnings and sales beat estimates. Management hikes the EPS guidance on the back of encouraging Skyrizi product sales.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/31/1512.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.998311"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.126215, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GMAB", "relevance_score": "0.112008", "ticker_sentiment_score": "0.281693", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABBV", "relevance_score": "0.327366", "ticker_sentiment_score": "0.299765", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.074809", "ticker_sentiment_score": "0.063534", "ticker_sentiment_label": "Neutral"}]}, {"title": "Are You Looking for a High-Growth Dividend Stock?", "url": "https://www.zacks.com/stock/news/2263489/are-you-looking-for-a-high-growth-dividend-stock", "time_published": "20240426T154509", "authors": ["Zacks Equity Research"], "summary": "Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default175.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.938238"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.999365"}], "overall_sentiment_score": 0.421112, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "JNJ", "relevance_score": "0.448316", "ticker_sentiment_score": "0.497143", "ticker_sentiment_label": "Bullish"}]}, {"title": "Stocks Rebound Amid Big-Cap Earnings: Weekly Review", "url": "https://www.investors.com/news/stock-market-rebounds-tesla-microsoft-google-meta-chipotle-ge-in-focus-weekly-review/", "time_published": "20240426T153400", "authors": ["Investor's Business Daily", "IBD STAFF"], "summary": "Stock Market Rebounds. Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2019/02/VIDEO-IBDDIFF-NYSE-020819-shutter.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Economy - Monetary", "relevance_score": "0.576289"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.999993"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "1.0"}], "overall_sentiment_score": 0.022015, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MEDP", "relevance_score": "0.033075", "ticker_sentiment_score": "0.224841", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MXL", "relevance_score": "0.033075", "ticker_sentiment_score": "-0.103259", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROKU", "relevance_score": "0.033075", "ticker_sentiment_score": "-0.001918", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVX", "relevance_score": "0.066093", "ticker_sentiment_score": "0.023298", "ticker_sentiment_label": "Neutral"}, {"ticker": "VZ", "relevance_score": "0.098998", "ticker_sentiment_score": "-0.03743", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.033075", "ticker_sentiment_score": "-0.060313", "ticker_sentiment_label": "Neutral"}, {"ticker": "NBIX", "relevance_score": "0.033075", "ticker_sentiment_score": "-0.060313", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXN", "relevance_score": "0.033075", "ticker_sentiment_score": "-0.103259", "ticker_sentiment_label": "Neutral"}, {"ticker": "STM", "relevance_score": "0.033075", "ticker_sentiment_score": "-0.103259", "ticker_sentiment_label": "Neutral"}, {"ticker": "URI", "relevance_score": "0.049595", "ticker_sentiment_score": "0.079806", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.11539", "ticker_sentiment_score": "0.136118", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.14802", "ticker_sentiment_score": "-0.032445", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLX", "relevance_score": "0.033075", "ticker_sentiment_score": "0.022472", "ticker_sentiment_label": "Neutral"}, {"ticker": "V", "relevance_score": "0.033075", "ticker_sentiment_score": "0.009549", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLO", "relevance_score": "0.033075", "ticker_sentiment_score": "0.022472", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRT", "relevance_score": "0.033075", "ticker_sentiment_score": "0.091842", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMG", "relevance_score": "0.066093", "ticker_sentiment_score": "0.103051", "ticker_sentiment_label": "Neutral"}, {"ticker": "GD", "relevance_score": "0.049595", "ticker_sentiment_score": "0.115876", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.082563", "ticker_sentiment_score": "0.139202", "ticker_sentiment_label": "Neutral"}, {"ticker": "GE", "relevance_score": "0.131733", "ticker_sentiment_score": "-0.001266", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUE", "relevance_score": "0.066093", "ticker_sentiment_score": "-0.074412", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.066093", "ticker_sentiment_score": "0.040467", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.131733", "ticker_sentiment_score": "0.004932", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.098998", "ticker_sentiment_score": "-0.003314", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOC", "relevance_score": "0.033075", "ticker_sentiment_score": "0.112318", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSX", "relevance_score": "0.033075", "ticker_sentiment_score": "0.159617", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GM", "relevance_score": "0.033075", "ticker_sentiment_score": "0.164521", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "OII", "relevance_score": "0.049595", "ticker_sentiment_score": "0.023", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.033075", "ticker_sentiment_score": "-0.000998", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMUS", "relevance_score": "0.049595", "ticker_sentiment_score": "-0.034001", "ticker_sentiment_label": "Neutral"}, {"ticker": "EW", "relevance_score": "0.033075", "ticker_sentiment_score": "0.159617", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HAL", "relevance_score": "0.049595", "ticker_sentiment_score": "0.023", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMT", "relevance_score": "0.033075", "ticker_sentiment_score": "0.112318", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZN", "relevance_score": "0.033075", "ticker_sentiment_score": "-0.000998", "ticker_sentiment_label": "Neutral"}, {"ticker": "INTC", "relevance_score": "0.033075", "ticker_sentiment_score": "-0.103259", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAT", "relevance_score": "0.082563", "ticker_sentiment_score": "0.097489", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOW", "relevance_score": "0.033075", "ticker_sentiment_score": "0.037093", "ticker_sentiment_label": "Neutral"}, {"ticker": "XOM", "relevance_score": "0.033075", "ticker_sentiment_score": "0.022472", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDNS", "relevance_score": "0.033075", "ticker_sentiment_score": "-0.08357", "ticker_sentiment_label": "Neutral"}, {"ticker": "GEV", "relevance_score": "0.066093", "ticker_sentiment_score": "-0.049623", "ticker_sentiment_label": "Neutral"}, {"ticker": "PI", "relevance_score": "0.033075", "ticker_sentiment_score": "-0.103259", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTI", "relevance_score": "0.049595", "ticker_sentiment_score": "0.023", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLF", "relevance_score": "0.049595", "ticker_sentiment_score": "-0.073841", "ticker_sentiment_label": "Neutral"}, {"ticker": "BA", "relevance_score": "0.082563", "ticker_sentiment_score": "-0.044057", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.033075", "ticker_sentiment_score": "-0.000998", "ticker_sentiment_label": "Neutral"}, {"ticker": "STLD", "relevance_score": "0.049595", "ticker_sentiment_score": "-0.073841", "ticker_sentiment_label": "Neutral"}]}, {"title": "5 Stocks in Focus on Their Recent Dividend Hike", "url": "https://www.zacks.com/stock/news/2263132/5-stocks-in-focus-on-their-recent-dividend-hike", "time_published": "20240426T121300", "authors": ["Nalak Das"], "summary": "Five stocks to focus with recent dividend hike are: JNJ, TRV, SON, KBH, SPFI.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/3c/1948.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.451494"}, {"topic": "Financial Markets", "relevance_score": "0.999997"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.682689"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}], "overall_sentiment_score": 0.195152, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "KBH", "relevance_score": "0.369319", "ticker_sentiment_score": "0.166401", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TRV", "relevance_score": "0.369319", "ticker_sentiment_score": "0.480674", "ticker_sentiment_label": "Bullish"}, {"ticker": "SON", "relevance_score": "0.299478", "ticker_sentiment_score": "0.212312", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTBK", "relevance_score": "0.038345", "ticker_sentiment_score": "0.061439", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPFI", "relevance_score": "0.334762", "ticker_sentiment_score": "0.144375", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.299478", "ticker_sentiment_score": "0.251639", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Cidara Therapeutics Announces Presentations Highlighting Phase 1 and Phase 2a Clinical Data on CD388 at ESCMID 2024 - Cidara Therapeutics  ( NASDAQ:CDTX ) ", "url": "https://www.benzinga.com/pressreleases/24/04/g38457396/cidara-therapeutics-announces-presentations-highlighting-phase-1-and-phase-2a-clinical-data-on-cd3", "time_published": "20240426T120000", "authors": ["Globe Newswire"], "summary": "SAN DIEGO, April 26, 2024 ( GLOBE NEWSWIRE ) -- Cidara Therapeutics, Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.155306, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CDTX", "relevance_score": "0.212425", "ticker_sentiment_score": "0.155088", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.07157", "ticker_sentiment_score": "0.073387", "ticker_sentiment_label": "Neutral"}]}, {"title": "BioNJ Announces Lineup for BioPartnering Conference", "url": "https://www.prnewswire.com/news-releases/bionj-announces-lineup-for-biopartnering-conference-302127910.html", "time_published": "20240425T182700", "authors": ["BioNJ"], "summary": "TRENTON, N.J., April 25, 2024 /PRNewswire/ -- BioNJ is pleased to host its 14th Annual BioPartnering Conference on Tuesday, May 14, at the Liberty Science Center in Jersey City. Sponsored by J.P.", "banner_image": "https://mma.prnewswire.com/media/2397912/BioNJ_BioPartnering_Conference_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.380824, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "PFE", "relevance_score": "0.097854", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.194242", "ticker_sentiment_score": "0.073971", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNY", "relevance_score": "0.097854", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monthly Depth Report: The Blind Leading The Confused - Shockwave Medical  ( NASDAQ:SWAV ) ", "url": "https://www.benzinga.com/opinion/24/04/38437069/monthly-depth-report-the-blind-leading-the-confused", "time_published": "20240425T155927", "authors": ["Gary Brode"], "summary": "One of the best experiences I've had in my investment career was being partner and co portfolio manager with Raji Khabbaz. He's a fantastic stock-picker and the two of us spent the better part of a decade discussing and debating investment ideas.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/04/25/nicholas-cappello-wb63zqj5gne-unsplash_1.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.999986"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.07264, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SWAV", "relevance_score": "0.028338", "ticker_sentiment_score": "0.085825", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.028338", "ticker_sentiment_score": "0.085825", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here Are My Top 5 Dividend Kings to Buy Right Now", "url": "https://www.fool.com/investing/2024/04/25/here-are-my-top-5-dividend-kings-to-buy-right-now/", "time_published": "20240425T131500", "authors": ["Adam Spatacco"], "summary": "Dividend Kings are hard to come by, but these five stocks offer investors some great passive income opportunities.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F773701%2Fcopy-of-dividends-blackboard-sketch-doodle.jpg&op=resize&w=700", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.999701"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.839681"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.319823, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "KVUE", "relevance_score": "0.137083", "ticker_sentiment_score": "0.13966", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOLV", "relevance_score": "0.03443", "ticker_sentiment_score": "0.190962", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MO", "relevance_score": "0.237469", "ticker_sentiment_score": "0.227408", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "KO", "relevance_score": "0.103035", "ticker_sentiment_score": "0.270812", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.068797", "ticker_sentiment_score": "0.145609", "ticker_sentiment_label": "Neutral"}, {"ticker": "WMT", "relevance_score": "0.237469", "ticker_sentiment_score": "0.19416", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "This Small-Cap Stock Is Up 140% This Year and Here's Why It Can Go Even Higher", "url": "https://www.fool.com/investing/2024/04/25/this-small-cap-stock-is-up-150-this-year-and-heres/", "time_published": "20240425T093700", "authors": ["David Jagielski"], "summary": "For investors with a high level of risk tolerance, Mind Medicine could be an intriguing investment option.", "banner_image": "https://media.ycharts.com/charts/887c4d12055417c81c6d752c80b64f41.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.503496"}], "overall_sentiment_score": 0.28068, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MNMD", "relevance_score": "0.575728", "ticker_sentiment_score": "0.317542", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.057907", "ticker_sentiment_score": "0.127985", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pre-Investor Call Presentation available to shareholders", "url": "https://www.globenewswire.com/news-release/2024/04/25/2869320/0/en/Pre-Investor-Call-Presentation-available-to-shareholders.html", "time_published": "20240425T064000", "authors": ["VIRTUALWARE 2007 SA"], "summary": "Investors can access and view today's presentation materials by following this link: Headquartered in Bilbao, Spain, Virtualware is a global pioneer in developing virtual reality solutions for large industrial, educational, and healthcare conglomerates.", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/6aee44c0-62ac-4f66-9be0-b3578d202005", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Earnings", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.20415, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GEV", "relevance_score": "0.073773", "ticker_sentiment_score": "0.119019", "ticker_sentiment_label": "Neutral"}, {"ticker": "IBDSF", "relevance_score": "0.073773", "ticker_sentiment_score": "0.119019", "ticker_sentiment_label": "Neutral"}, {"ticker": "AOMFF", "relevance_score": "0.073773", "ticker_sentiment_score": "0.119019", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.073773", "ticker_sentiment_score": "0.119019", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.073773", "ticker_sentiment_score": "0.119019", "ticker_sentiment_label": "Neutral"}]}, {"title": "Investing in Cardiovascular MedTech Companies", "url": "https://investingnews.com/investing-in-cardiovascular-medtech-companies/", "time_published": "20240424T224704", "authors": ["Investing News Network"], "summary": "Efforts to address the core risk factors associated with cardiovascular diseases are coinciding with recent innovations in medical technology, which have been critical in not only preventing and managing them but also increasing the survival rate.", "banner_image": "https://investingnews.com/media-library/illustration-of-heart-attack.png?id=52093924&width=1200&height=800&quality=85&coordinates=0%2C0%2C0%2C0", "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.426531, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "CDEXF", "relevance_score": "0.101725", "ticker_sentiment_score": "0.094903", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.101725", "ticker_sentiment_score": "0.089634", "ticker_sentiment_label": "Neutral"}, {"ticker": "WLDS", "relevance_score": "0.03399", "ticker_sentiment_score": "0.205849", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BSX", "relevance_score": "0.101725", "ticker_sentiment_score": "0.089634", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.03399", "ticker_sentiment_score": "0.084292", "ticker_sentiment_label": "Neutral"}]}, {"title": "NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results", "url": "https://www.globenewswire.com/news-release/2024/04/24/2869144/0/en/NANOBIOTIX-Provides-Business-Update-and-Reports-Full-Year-2023-Financial-Results.html", "time_published": "20240424T204000", "authors": ["Nanobiotix S.A."], "summary": "Conference call and webcast scheduled for April 25, 2024 at 8:00 A.M. EDT / 2:00 P.M. CEST ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/36fb7b98-27d7-46cb-b989-fa31626657b8", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.744043"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.94762"}], "overall_sentiment_score": 0.116494, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NBTX", "relevance_score": "0.298749", "ticker_sentiment_score": "0.101264", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIANY", "relevance_score": "0.015304", "ticker_sentiment_score": "0.082886", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.030602", "ticker_sentiment_score": "0.075618", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NANO", "relevance_score": "0.015304", "ticker_sentiment_score": "0.047629", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's a rapid-fire update on all 33 portfolio stocks including our tech giants reporting this week", "url": "https://www.cnbc.com/2024/04/24/jim-cramers-rapid-fire-update-on-all-33-investing-club-stocks.html", "time_published": "20240424T195309", "authors": ["Kevin Stankiewicz", "Morgan Chittum"], "summary": "During the Investing Club's Monthly Meeting on Wednesday, Jim Cramer offered his updated thinking on the stocks in the portfolio.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107381791-1709565572170-gettyimages-2050810312-AFP_34KQ4DT.jpeg?v=1713980195&w=1920&h=1080", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Economy - Monetary", "relevance_score": "0.451494"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.999974"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": 0.147834, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DD", "relevance_score": "0.014239", "ticker_sentiment_score": "0.054481", "ticker_sentiment_label": "Neutral"}, {"ticker": "VMW", "relevance_score": "0.014239", "ticker_sentiment_score": "0.054481", "ticker_sentiment_label": "Neutral"}, {"ticker": "INFA", "relevance_score": "0.028473", "ticker_sentiment_score": "0.058975", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVGO", "relevance_score": "0.014239", "ticker_sentiment_score": "0.054481", "ticker_sentiment_label": "Neutral"}, {"ticker": "F", "relevance_score": "0.014239", "ticker_sentiment_score": "0.054481", "ticker_sentiment_label": "Neutral"}, {"ticker": "FL", "relevance_score": "0.042698", "ticker_sentiment_score": "0.061498", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.014239", "ticker_sentiment_score": "0.054481", "ticker_sentiment_label": "Neutral"}, {"ticker": "WYNN", "relevance_score": "0.014239", "ticker_sentiment_score": "0.054481", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNH", "relevance_score": "0.014239", "ticker_sentiment_score": "0.054481", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.05691", "ticker_sentiment_score": "0.062053", "ticker_sentiment_label": "Neutral"}, {"ticker": "COST", "relevance_score": "0.042698", "ticker_sentiment_score": "0.061498", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.014239", "ticker_sentiment_score": "0.054481", "ticker_sentiment_label": "Neutral"}, {"ticker": "WFC", "relevance_score": "0.042698", "ticker_sentiment_score": "0.061498", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBY", "relevance_score": "0.042698", "ticker_sentiment_score": "0.061498", "ticker_sentiment_label": "Neutral"}, {"ticker": "STZ", "relevance_score": "0.014239", "ticker_sentiment_score": "0.054481", "ticker_sentiment_label": "Neutral"}, {"ticker": "PANW", "relevance_score": "0.014239", "ticker_sentiment_score": "0.054481", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.042698", "ticker_sentiment_score": "0.061498", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.028473", "ticker_sentiment_score": "0.058975", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.028473", "ticker_sentiment_score": "0.058975", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRWD", "relevance_score": "0.014239", "ticker_sentiment_score": "0.054481", "ticker_sentiment_label": "Neutral"}, {"ticker": "TJX", "relevance_score": "0.028473", "ticker_sentiment_score": "0.058975", "ticker_sentiment_label": "Neutral"}, {"ticker": "GM", "relevance_score": "0.042698", "ticker_sentiment_score": "0.061498", "ticker_sentiment_label": "Neutral"}, {"ticker": "HON", "relevance_score": "0.014239", "ticker_sentiment_score": "0.054481", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.028473", "ticker_sentiment_score": "0.058975", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWK", "relevance_score": "0.014239", "ticker_sentiment_score": "0.054481", "ticker_sentiment_label": "Neutral"}, {"ticker": "PG", "relevance_score": "0.014239", "ticker_sentiment_score": "0.054481", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTRA", "relevance_score": "0.014239", "ticker_sentiment_score": "0.054481", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:USD", "relevance_score": "0.014239", "ticker_sentiment_score": "0.054481", "ticker_sentiment_label": "Neutral"}]}, {"title": "Vanda  ( VNDA )  to Report Q1 Earnings: What's in the Cards?", "url": "https://www.zacks.com/stock/news/2261585/vanda-vnda-to-report-q1-earnings-whats-in-the-cards", "time_published": "20240424T175800", "authors": ["Zacks Equity Research"], "summary": "On Vanda's (VNDA) first-quarter 2024 earnings call, investors' focus is likely to be on the sales performance of its marketed drugs and certain pipeline and regulatory updates.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/49/1007.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999992"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.109272, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.190793", "ticker_sentiment_score": "-0.003041", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSSMY", "relevance_score": "0.048133", "ticker_sentiment_score": "-0.071085", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRPT", "relevance_score": "0.1437", "ticker_sentiment_score": "0.171113", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VNDA", "relevance_score": "0.327366", "ticker_sentiment_score": "0.028564", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.1437", "ticker_sentiment_score": "0.159788", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?", "url": "https://www.zacks.com/stock/news/2261011/whats-in-store-for-these-5-pharma-bigwigs-in-q1-earnings", "time_published": "20240424T131900", "authors": ["Ahan Chakraborty"], "summary": "Let's look at five biotech/drug companies, MRK, SNY, BMY, GILD and ABBV, slated to release their first quarter 2024 earnings results this week.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/ad/58479.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.154863, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AZN", "relevance_score": "0.039614", "ticker_sentiment_score": "-0.008857", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.039614", "ticker_sentiment_score": "-0.080241", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVS", "relevance_score": "0.039614", "ticker_sentiment_score": "0.342197", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABBV", "relevance_score": "0.234307", "ticker_sentiment_score": "0.134722", "ticker_sentiment_label": "Neutral"}, {"ticker": "GILD", "relevance_score": "0.196132", "ticker_sentiment_score": "-0.010985", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.118452", "ticker_sentiment_score": "0.061763", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNY", "relevance_score": "0.196132", "ticker_sentiment_score": "0.04485", "ticker_sentiment_label": "Neutral"}]}, {"title": "The Zacks Analyst Blog Highlights KB Home, Interactive Brokers Group, Qualcomm and Johnson & Johnson", "url": "https://www.zacks.com/stock/news/2261200/the-zacks-analyst-blog-highlights-kb-home-interactive-brokers-group-qualcomm-and-johnson-johnson", "time_published": "20240424T125000", "authors": ["Zacks Equity Research"], "summary": "KB Home, Interactive Brokers Group, Qualcomm and Johnson & Johnson are part of the Zacks top Analyst Blog.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/0d/701.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.838487"}, {"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.055662, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "KBH", "relevance_score": "0.414559", "ticker_sentiment_score": "0.193751", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "IBKR", "relevance_score": "0.28387", "ticker_sentiment_score": "0.098158", "ticker_sentiment_label": "Neutral"}, {"ticker": "QCOM", "relevance_score": "0.28387", "ticker_sentiment_score": "0.110411", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.414559", "ticker_sentiment_score": "0.269325", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "These Are the 10 High-Profile Stocks U.S. Politicians Have Gravitated to Most Over the Last 3 Years", "url": "https://www.fool.com/investing/2024/04/24/these-are-the-10-high-profile-stocks-us-politician/", "time_published": "20240424T101000", "authors": ["Keith Speights"], "summary": "These stocks kept members of Congress especially busy.", "banner_image": "https://g.foolcdn.com/editorial/images/773947/congress-building-capitol-hill.jpg", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": 0.19698, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.201021", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYPL", "relevance_score": "0.201021", "ticker_sentiment_score": "0.102999", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.081138", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.121445", "ticker_sentiment_score": "0.251165", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AAPL", "relevance_score": "0.201021", "ticker_sentiment_score": "0.093886", "ticker_sentiment_label": "Neutral"}, {"ticker": "T", "relevance_score": "0.16144", "ticker_sentiment_score": "0.277091", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VZ", "relevance_score": "0.353338", "ticker_sentiment_score": "0.193378", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.16144", "ticker_sentiment_score": "0.109402", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.16144", "ticker_sentiment_score": "0.190746", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Got $5,000? Here Are 3 Undervalued Stocks to Buy and Hold Forever", "url": "https://www.fool.com/investing/2024/04/24/got-5000-here-are-3-undervalued-stocks-to-buy-and/", "time_published": "20240424T092500", "authors": ["Justin Pope"], "summary": "Buying great stocks when they're on sale is a lucrative long-term strategy.", "banner_image": "https://g.foolcdn.com/editorial/images/772025/opportunity.jpg", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.999987"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.576289"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.247998, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BUD", "relevance_score": "0.050894", "ticker_sentiment_score": "0.085012", "ticker_sentiment_label": "Neutral"}, {"ticker": "MO", "relevance_score": "0.298264", "ticker_sentiment_score": "0.263966", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.298264", "ticker_sentiment_score": "-0.024182", "ticker_sentiment_label": "Neutral"}, {"ticker": "O", "relevance_score": "0.298264", "ticker_sentiment_score": "0.290453", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi\u00ae  ( golimumab ) ", "url": "https://www.globenewswire.com/news-release/2024/04/24/2868337/0/en/Alvotech-Announces-Topline-Results-from-a-Confirmatory-Clinical-Study-for-AVT05-a-Proposed-Biosimilar-for-Simponi-golimumab.html", "time_published": "20240424T080000", "authors": ["Alvotech"], "summary": "Alvotech ( NASDAQ: ALVO ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today positive topline results from a confirmatory clinical study for AVT05, Alvotech's proposed biosimilar to Simponi\u00ae and Simponi Aria\u00ae ...", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/17a8091d-68a6-47c1-968e-fcced99f1d44", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.128088, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ALVO", "relevance_score": "0.529556", "ticker_sentiment_score": "0.226967", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TEVA", "relevance_score": "0.025034", "ticker_sentiment_score": "0.059121", "ticker_sentiment_label": "Neutral"}, {"ticker": "KMDA", "relevance_score": "0.025034", "ticker_sentiment_score": "0.059121", "ticker_sentiment_label": "Neutral"}, {"ticker": "LTUS", "relevance_score": "0.025034", "ticker_sentiment_score": "0.059121", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.025034", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "The No. 1 Biotech Stock Just Launched Higher - Here's Why", "url": "https://www.investors.com/news/technology/biotech-stock-neurocrine-stock-depression-treatment-win/", "time_published": "20240423T132000", "authors": ["Investor's Business Daily", "ALLISON GATLIN"], "summary": "Biotech Stock Neurocrine Launches Higher On A Depression Treatment Win Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2022/08/Stock-neurocrinebio-01-shutt.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.955357"}], "overall_sentiment_score": 0.184606, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PFE", "relevance_score": "0.156461", "ticker_sentiment_score": "-0.118245", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.306963", "ticker_sentiment_score": "0.288375", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NBIX", "relevance_score": "0.306963", "ticker_sentiment_score": "0.334376", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TAK", "relevance_score": "0.306963", "ticker_sentiment_score": "0.334376", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "4 Stocks to Watch on Their Recent Dividend Hikes", "url": "https://www.zacks.com/stock/news/2260121/4-stocks-to-watch-on-their-recent-dividend-hikes", "time_published": "20240423T124200", "authors": ["Ritujay Ghosh"], "summary": "Stocks like KB Home (KBH), Interactive Brokers Group, Inc. (IBKR), QUALCOMM Incorporated (QCOM) and Johnson & Johnson (JNJ) recently hiked dividends.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f2/1790.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.838487"}, {"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.038911, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "KBH", "relevance_score": "0.415413", "ticker_sentiment_score": "0.247372", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "IBKR", "relevance_score": "0.267413", "ticker_sentiment_score": "0.12852", "ticker_sentiment_label": "Neutral"}, {"ticker": "QCOM", "relevance_score": "0.215415", "ticker_sentiment_score": "0.121113", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.415413", "ticker_sentiment_score": "0.35555", "ticker_sentiment_label": "Bullish"}]}, {"title": "TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger - ALPN, LABP, SWAV, FUSN", "url": "https://www.benzinga.com/pressreleases/24/04/g38366584/take-action-the-m-a-class-action-firm-launches-legal-inquiry-for-the-merger-alpn-labp-swav-fusn", "time_published": "20240422T213316", "authors": ["Globe Newswire"], "summary": "NEW YORK, April 22, 2024 ( GLOBE NEWSWIRE ) -- Monteverde & Associates PC ( the \"M&A Class Action Firm\" ) , has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.650727"}], "overall_sentiment_score": 0.270721, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "LABP", "relevance_score": "0.334008", "ticker_sentiment_score": "0.312006", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ALPN", "relevance_score": "0.334008", "ticker_sentiment_score": "0.281733", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.085936", "ticker_sentiment_score": "0.124976", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRTX", "relevance_score": "0.085936", "ticker_sentiment_score": "0.124976", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.085936", "ticker_sentiment_score": "0.139374", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUSN", "relevance_score": "0.334008", "ticker_sentiment_score": "0.312006", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SWAV", "relevance_score": "0.334008", "ticker_sentiment_score": "0.281733", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Macatawa Bank Corporation  ( Nasdaq - MCBC ) , Shockwave Medical, Inc.  ( Nasdaq - SWAV ) , Apartment Income REIT Corp.  ( NYSE - AIRC ) , Model N, Inc.  ( NYSE - MODN ) ", "url": "https://www.benzinga.com/pressreleases/24/04/g38360727/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-macatawa-bank", "time_published": "20240422T155334", "authors": ["Globe Newswire"], "summary": "BALA CYNWYD, Pa., April 22, 2024 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( jbrodsky@brodskysmith.com ) or Marc Ackerman ( mackerman@brodskysmith.com ) at 855-576-4847.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.998333"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.918141"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.253232, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "WTFC", "relevance_score": "0.136113", "ticker_sentiment_score": "0.222469", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MCBC", "relevance_score": "0.068306", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSSMY", "relevance_score": "0.202932", "ticker_sentiment_score": "0.058294", "ticker_sentiment_label": "Neutral"}, {"ticker": "BX", "relevance_score": "0.202932", "ticker_sentiment_score": "0.162385", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AIRC", "relevance_score": "0.068306", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.202932", "ticker_sentiment_score": "0.177581", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MODN", "relevance_score": "0.268294", "ticker_sentiment_score": "0.155883", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SWAV", "relevance_score": "0.068306", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WIRE, ABIO, SWAV, MODN - Model N  ( NYSE:MODN ) , ARCA biopharma  ( NASDAQ:ABIO ) ", "url": "https://www.benzinga.com/pressreleases/24/04/g38359734/shareholder-investigation-halper-sadeh-llc-investigates-wire-abio-swav-modn", "time_published": "20240422T151032", "authors": ["Globe Newswire"], "summary": "NEW YORK, April 22, 2024 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.128619, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MODN", "relevance_score": "0.213988", "ticker_sentiment_score": "0.126999", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABIO", "relevance_score": "0.107978", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WIRE", "relevance_score": "0.107978", "ticker_sentiment_score": "0.084761", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWAV", "relevance_score": "0.107978", "ticker_sentiment_score": "0.084761", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.107978", "ticker_sentiment_score": "0.084761", "ticker_sentiment_label": "Neutral"}]}, {"title": "Kuehn Law Encourages WIRE, ABIO, MODN, and SWAV Investors to Contact Law Firm - Model N  ( NYSE:MODN ) , ARCA biopharma  ( NASDAQ:ABIO ) ", "url": "https://www.benzinga.com/pressreleases/24/04/g38357464/kuehn-law-encourages-wire-abio-modn-and-swav-investors-to-contact-law-firm", "time_published": "20240422T134703", "authors": ["Globe Newswire"], "summary": "NEW YORK, April 22, 2024 ( GLOBE NEWSWIRE ) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.360215"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.295874, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MODN", "relevance_score": "0.234684", "ticker_sentiment_score": "0.333119", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABIO", "relevance_score": "0.118647", "ticker_sentiment_score": "0.127461", "ticker_sentiment_label": "Neutral"}, {"ticker": "WIRE", "relevance_score": "0.234684", "ticker_sentiment_score": "0.459878", "ticker_sentiment_label": "Bullish"}, {"ticker": "SWAV", "relevance_score": "0.118647", "ticker_sentiment_score": "0.282229", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.118647", "ticker_sentiment_score": "0.282229", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Johnson & Johnson  ( JNJ )  Is a Trending Stock: Facts to Know Before Betting on It", "url": "https://www.zacks.com/stock/news/2259015/johnson-johnson-jnj-is-a-trending-stock-facts-to-know-before-betting-on-it", "time_published": "20240422T130016", "authors": ["Zacks Equity Research"], "summary": "Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default47.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999999"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}], "overall_sentiment_score": 0.224611, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "JNJ", "relevance_score": "0.473208", "ticker_sentiment_score": "0.114889", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stock market today: US futures climb as traders await crucial 'Magnificent 7' earnings reports", "url": "https://africa.businessinsider.com/markets/stock-market-today-us-futures-climb-as-traders-await-crucial-magnificent-7-earnings/mk3wwc1", "time_published": "20240422T101016", "authors": ["George Glover"], "summary": "Samp;P 500 futures were up 0.5% shortly before 6 a.m. ET, while Nasdaq 100 futures had climbed 0.6%. The Dow Jones Industrial Average was on pace to add 165 points.", "banner_image": "https://ocdn.eu/pulscms-transforms/1/_xektkuTURBXy8wN2RmMWYwOC0zN2Q5LTRhZWEtYjEyOS1hYTM0YTViYzRiZTYuanBlZ5GTBc0DFs0Brg", "source": "Business Insider", "category_within_source": "GoogleRSS", "source_domain": "africa.businessinsider.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.219403, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.162802", "ticker_sentiment_score": "0.223261", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TSLA", "relevance_score": "0.162802", "ticker_sentiment_score": "0.223261", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.162802", "ticker_sentiment_score": "0.223261", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "XOM", "relevance_score": "0.162802", "ticker_sentiment_score": "0.223261", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FOREX:USD", "relevance_score": "0.162802", "ticker_sentiment_score": "0.070605", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stock market today: US futures climb as traders await crucial 'Magnificent 7' earnings reports", "url": "https://www.businessinsider.com/stock-market-today-microsoft-alphabet-meta-tesla-magnificent-seven-earnings-2024-4", "time_published": "20240422T101000", "authors": ["George Glover"], "summary": "Stock market today: US futures climb ahead of Magnificent 7 earnings - Business Insider ...", "banner_image": null, "source": "Business Insider", "category_within_source": "GoogleRSS", "source_domain": "www.businessinsider.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.576289"}, {"topic": "Financial Markets", "relevance_score": "0.650727"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.576289"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.110583, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.232439", "ticker_sentiment_score": "0.138028", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.232439", "ticker_sentiment_score": "0.138028", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.117486", "ticker_sentiment_score": "0.121385", "ticker_sentiment_label": "Neutral"}, {"ticker": "XOM", "relevance_score": "0.117486", "ticker_sentiment_score": "0.121385", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:USD", "relevance_score": "0.117486", "ticker_sentiment_score": "0.121385", "ticker_sentiment_label": "Neutral"}]}, {"title": "Court Orders Johnson & Johnson And Kenvue To Pay $45 Million In Talcum Baby Powder Lawsuit", "url": "https://www.forbes.com/sites/caileygleeson/2024/04/20/court-orders-johnson--johnson-and-kenvue-to-pay-45-million-in-talcum-baby-powder-lawsuit/", "time_published": "20240420T192555", "authors": ["Cailey Gleeson"], "summary": "An Illinois court late Friday ordered pharmaceutical giant Johnson & Johnson and Kenvue to pay $45 million to a family that alleged the companies' talcum-based baby powder led to the death of a relative diagnosed with a fatal cancer linked to asbestos exposure, the company's latest legal issue ...", "banner_image": "https://imageio.forbes.com/specials-images/imageserve/66241662c228281a35936eab/0x0.jpg?format=jpg&crop=3000,1687,x0,y0,safe&height=900&width=1600&fit=bounds", "source": "Forbes", "category_within_source": "n/a", "source_domain": "www.forbes.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.196063, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "KVUE", "relevance_score": "0.144708", "ticker_sentiment_score": "-0.05911", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.47672", "ticker_sentiment_score": "-0.257595", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Don't Let Media-Driven Fears Keep You From These 7%+ Dividends", "url": "https://www.forbes.com/sites/michaelfoster/2024/04/20/dont-let-media-driven-fears-keep-you-from-these-7-dividends/", "time_published": "20240420T133600", "authors": ["Michael Foster"], "summary": "It's starting again-the media has its hooks into a new story to scare investors, in yet another effort to gain attention. The upshot is that we've now got a very nice opportunity to pick up a special kind of closed-end fund ( CEF ) that yields 7%+ and does something unusual to limit downside.", "banner_image": "https://imageio.forbes.com/specials-images/imageserve/661fd70b850da1386d0dd00c/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds", "source": "Forbes", "category_within_source": "n/a", "source_domain": "www.forbes.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.451494"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.041812, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.079788", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.079788", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WMT", "relevance_score": "0.079788", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Endoscopy Devices Market size is set to grow by USD 14.24 billion from 2024-2028, advances in endoscopy ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/endoscopy-devices-market-size-is-set-to-grow-by-usd-14-24-billion-from-2024-2028--advances-in-endoscopy-technologies-boost-the-market--technavio-302120829.html", "time_published": "20240419T221200", "authors": [], "summary": "Endoscopy Devices Market size is set to grow by USD 14.24 billion from 2024-2028, advances in endoscopy ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Manufacturing", "relevance_score": "0.5"}], "overall_sentiment_score": 0.206034, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SYK", "relevance_score": "0.033656", "ticker_sentiment_score": "0.036539", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLAR", "relevance_score": "0.033656", "ticker_sentiment_score": "0.036539", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSX", "relevance_score": "0.033656", "ticker_sentiment_score": "0.036539", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.033656", "ticker_sentiment_score": "0.036539", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUJIF", "relevance_score": "0.033656", "ticker_sentiment_score": "0.036539", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.033656", "ticker_sentiment_score": "0.036539", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCPNF", "relevance_score": "0.033656", "ticker_sentiment_score": "0.036539", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNMD", "relevance_score": "0.033656", "ticker_sentiment_score": "0.036539", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCSG", "relevance_score": "0.067252", "ticker_sentiment_score": "0.074881", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stock Market Shows Bearish Action: Weekly Review", "url": "https://www.investors.com/news/stock-market-taiwan-semiconductor-asml-netflix-united-airlines-weekly-review/", "time_published": "20240419T165100", "authors": ["IBD STAFF", "Investor's Business Daily"], "summary": "Stock Market Sells Off. Taiwan Semi, ASML, Netflix, Tesla In Focus: Weekly Review Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2020/10/Stock-NYSEbuilding-09-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": 0.041784, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.172097", "ticker_sentiment_score": "-0.148103", "ticker_sentiment_label": "Neutral"}, {"ticker": "UAL", "relevance_score": "0.098862", "ticker_sentiment_score": "-0.034689", "ticker_sentiment_label": "Neutral"}, {"ticker": "IBKR", "relevance_score": "0.098862", "ticker_sentiment_score": "0.102009", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.07423", "ticker_sentiment_score": "0.108439", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.07423", "ticker_sentiment_score": "0.108439", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.049526", "ticker_sentiment_score": "0.071953", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLB", "relevance_score": "0.123399", "ticker_sentiment_score": "0.018007", "ticker_sentiment_label": "Neutral"}, {"ticker": "BK", "relevance_score": "0.07423", "ticker_sentiment_score": "0.108439", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.049526", "ticker_sentiment_score": "0.105983", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNH", "relevance_score": "0.07423", "ticker_sentiment_score": "0.108869", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSM", "relevance_score": "0.07423", "ticker_sentiment_score": "0.004134", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBH", "relevance_score": "0.049526", "ticker_sentiment_score": "0.102972", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.049526", "ticker_sentiment_score": "0.071953", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITCI", "relevance_score": "0.049526", "ticker_sentiment_score": "-0.127853", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.172097", "ticker_sentiment_score": "-0.076438", "ticker_sentiment_label": "Neutral"}, {"ticker": "PG", "relevance_score": "0.049526", "ticker_sentiment_score": "0.107278", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLY", "relevance_score": "0.07423", "ticker_sentiment_score": "0.101928", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXP", "relevance_score": "0.049526", "ticker_sentiment_score": "0.012", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCHW", "relevance_score": "0.07423", "ticker_sentiment_score": "0.095435", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.07423", "ticker_sentiment_score": "0.088742", "ticker_sentiment_label": "Neutral"}, {"ticker": "BA", "relevance_score": "0.07423", "ticker_sentiment_score": "0.0156", "ticker_sentiment_label": "Neutral"}]}, {"title": "WHO says wider warning about contaminated J&J cough syrup 'likely'", "url": "https://www.business-standard.com/world-news/who-says-wider-warning-about-contaminated-j-j-cough-syrup-likely-124041901148_1.html", "time_published": "20240419T145440", "authors": ["Reuters"], "summary": "The World Health Organization is likely to issue a wider warning about contaminated Johnson and Johnson-made children's cough syrup found in Nigeria last week, it said in an email. Nigeria's regulator recalled a batch of Benylin syrup last Wednesday, having found a high level of diethylene glycol ...", "banner_image": "https://bsmedia.business-standard.com/_media/bs/img/article/2023-05/16/full/1684234463-8764.jpg?im=FeatureCrop,size=(826,465)", "source": "Business Standard", "category_within_source": "GoogleRSS", "source_domain": "www.business-standard.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.097247, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "KVUE", "relevance_score": "0.331765", "ticker_sentiment_score": "-0.070615", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.085324", "ticker_sentiment_score": "-0.243445", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "A creator made 5 figures with a dating podcast and quit her job to focus on her side hustle full-time. She breaks down her income from brand deals, sponsored events, and more.", "url": "https://www.businessinsider.com/how-much-creator-earns-tiktok-instagram-events-brand-deals-podcast-2024-4", "time_published": "20240419T144000", "authors": ["Shriya Bhattacharya"], "summary": "How Much a Creator Makes in a Year From Events, Brand Deals, TikTok - Business Insider ...", "banner_image": null, "source": "Business Insider", "category_within_source": "GoogleRSS", "source_domain": "www.businessinsider.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.149059, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "JNJ", "relevance_score": "0.042953", "ticker_sentiment_score": "0.169258", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Johnson & Johnson Children's Cough Syrup Contaminated In Some Batches - WHO Poised to Issue Global Alert - Johnson & Johnson  ( NYSE:JNJ ) ", "url": "https://www.benzinga.com/general/biotech/24/04/38335588/johnson-johnson-childrens-cough-syrup-contaminated-in-some-batches-who-poised-to-issue-global-ale", "time_published": "20240419T141714", "authors": ["Vandana Singh"], "summary": "The World Health Organization ( WHO ) is poised to issue a broader alert regarding contaminated children's cough syrup produced by Johnson and Johnson JNJ in response to the discovery of tainted batches in Nigeria.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/04/19/Benylin-Syrup.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.076471, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "KVUE", "relevance_score": "0.414559", "ticker_sentiment_score": "0.150091", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.414559", "ticker_sentiment_score": "-0.057089", "ticker_sentiment_label": "Neutral"}]}, {"title": "White River Bancshares Co. Earns $509,000, or $0.51 Per Diluted Share, in First Quarter 2024; Highlighted by Higher Net Interest Income and Double Digit Loan and Deposit Growth Year-Over-Year", "url": "https://www.globenewswire.com/news-release/2024/04/19/2866167/0/en/White-River-Bancshares-Co-Earns-509-000-or-0-51-Per-Diluted-Share-in-First-Quarter-2024-Highlighted-by-Higher-Net-Interest-Income-and-Double-Digit-Loan-and-Deposit-Growth-Year-Over.html", "time_published": "20240419T130000", "authors": ["White River Bancshares"], "summary": "FAYETTEVILLE, Ark., April 19, 2024 ( GLOBE NEWSWIRE ) -- White River Bancshares Company ( OTCQX: WRIV ) , ( the \"Company\" ) the holding company for Signature Bank of Arkansas ( the \"Bank\" ) , today reported net income of $509,000, or $0.51 per diluted share, in the first quarter of 2024, ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/59f98c26-e808-41b4-b248-610c5133e898", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.451494"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.999993"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.246729, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "KO", "relevance_score": "0.017729", "ticker_sentiment_score": "0.117576", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBNY", "relevance_score": "0.07083", "ticker_sentiment_score": "0.090446", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSN", "relevance_score": "0.017729", "ticker_sentiment_score": "0.117576", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.017729", "ticker_sentiment_score": "0.117576", "ticker_sentiment_label": "Neutral"}, {"ticker": "PG", "relevance_score": "0.017729", "ticker_sentiment_score": "0.117576", "ticker_sentiment_label": "Neutral"}, {"ticker": "WMT", "relevance_score": "0.017729", "ticker_sentiment_score": "0.117576", "ticker_sentiment_label": "Neutral"}]}, {"title": "The Zacks Analyst Blog Highlights NVIDIA, Alphabet, Johnson & Johnson, Broadridge Financial and Textron", "url": "https://www.zacks.com/stock/news/2258173/the-zacks-analyst-blog-highlights-nvidia-alphabet-johnson-johnson-broadridge-financial-and-textron", "time_published": "20240419T100000", "authors": ["Zacks Investment Research"], "summary": "NVIDIA, Alphabet, Johnson & Johnson, Broadridge Financial and Textron are included in this Analyst Blog.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/20/444.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.216801, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BR", "relevance_score": "0.17715", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.089129", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.262994", "ticker_sentiment_score": "0.158228", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TXT", "relevance_score": "0.17715", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.262994", "ticker_sentiment_score": "-0.017817", "ticker_sentiment_label": "Neutral"}]}, {"title": "Top Stock Reports for NVIDIA, Alphabet & Johnson & Johnson", "url": "https://www.zacks.com/research-daily/2257574/top-stock-reports-for-nvidia-alphabet-johnson-johnson", "time_published": "20240418T162200", "authors": ["Sheraz Mian"], "summary": "Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Alphabet Inc. (GOOGL) and Johnson & Johnson (JNJ).", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default206.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Manufacturing", "relevance_score": "0.5"}], "overall_sentiment_score": 0.237309, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NVDA", "relevance_score": "0.12165", "ticker_sentiment_score": "0.163365", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.12165", "ticker_sentiment_score": "-0.021593", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's Why You Should Retain Medtronic  ( MDT )  Stock for Now", "url": "https://www.zacks.com/stock/news/2257854/heres-why-you-should-retain-medtronic-mdt-stock-for-now", "time_published": "20240418T150900", "authors": ["Zacks Equity Research"], "summary": "Investors continue to be optimistic about Medtronic (MDT) due to the strength of its Neurosurgery and Cardiovascular portfolios.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}, {"topic": "Earnings", "relevance_score": "0.838487"}], "overall_sentiment_score": 0.299826, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SYK", "relevance_score": "0.038906", "ticker_sentiment_score": "0.047187", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSX", "relevance_score": "0.038906", "ticker_sentiment_score": "0.047187", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.038906", "ticker_sentiment_score": "0.047187", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMAT", "relevance_score": "0.116348", "ticker_sentiment_score": "0.080369", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAH", "relevance_score": "0.154703", "ticker_sentiment_score": "0.08129", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.339356", "ticker_sentiment_score": "0.367527", "ticker_sentiment_label": "Bullish"}, {"ticker": "DVA", "relevance_score": "0.116348", "ticker_sentiment_score": "0.103952", "ticker_sentiment_label": "Neutral"}]}, {"title": "Unpacking the Latest Options Trading Trends in Johnson & Johnson - Johnson & Johnson  ( NYSE:JNJ ) ", "url": "https://www.benzinga.com/insights/options/24/04/38316280/unpacking-the-latest-options-trading-trends-in-johnson-johnson", "time_published": "20240418T143229", "authors": ["Benzinga Insights"], "summary": "Financial giants have made a conspicuous bearish move on Johnson & Johnson. Our analysis of options history for Johnson & Johnson JNJ revealed 9 unusual trades. Delving into the details, we found 44% of traders were bullish, while 55% showed bearish tendencies.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.977154"}, {"topic": "Earnings", "relevance_score": "0.495866"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.172541, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "KVUE", "relevance_score": "0.075635", "ticker_sentiment_score": "0.140603", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.075635", "ticker_sentiment_score": "0.095982", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.703655", "ticker_sentiment_score": "0.326391", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Home Depot Primed For Bounce; How To Capitalize With Options", "url": "https://www.investors.com/research/options/home-depot-stock-option-trading/", "time_published": "20240418T123700", "authors": ["Investor's Business Daily", "GAVIN McMASTER"], "summary": "Home Depot Primed For Bounce. How To Capitalize With Options Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2017/11/Stock-homeDepot-01-company.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.623304"}], "overall_sentiment_score": -0.064503, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "HD", "relevance_score": "0.723894", "ticker_sentiment_score": "-0.09988", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.15697", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Johnson & Johnson Shares Hold Steady After Q1 Earnings, Analysts Optimistic About Future - Johnson & Johnson  ( NYSE:JNJ ) ", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38300896/johnson-johnson-shares-hold-steady-after-q1-earnings-analysts-optimistic-about-futu", "time_published": "20240417T193734", "authors": ["Vandana Singh"], "summary": "On Tuesday, Johnson & Johnson JNJ reported first-quarter adjusted EPS of $2.71, up 12.4% year over year, beating the consensus of $2.64. The pharma giant reported sales of $21.38 billion, up 2.3% year over year, almost in line with the consensus of $21.39 billion.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/04/17/Johnson-and-Johnson.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.288591, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GS", "relevance_score": "0.350564", "ticker_sentiment_score": "0.023023", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.636698", "ticker_sentiment_score": "0.416276", "ticker_sentiment_label": "Bullish"}]}, {"title": "Johnson & Johnson Analysts Cut Their Forecasts After Q1 Results - Johnson & Johnson  ( NYSE:JNJ ) ", "url": "https://www.benzinga.com/news/earnings/24/04/38299178/johnson-johnson-analysts-cut-their-forecasts-after-q1-results", "time_published": "20240417T175123", "authors": ["Avi Kapoor"], "summary": "Johnson & Johnson JNJ reported better-than-expected first-quarter earnings on Tuesday. The company posted adjusted EPS of $2.71, up 12.4% year over year, beating the consensus of $2.64.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/04/17/johnson__johnson_-_logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.77141"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.120179, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "JNJ", "relevance_score": "0.914521", "ticker_sentiment_score": "0.16504", "ticker_sentiment_label": "Somewhat-Bullish"}]}]}